Literature DB >> 28101803

Lung retransplantation in an adult 13 years after single lobar transplant in childhood.

Seiichiro Sugimoto1, Shinji Otani2, Takashi Ohki3, Takeshi Kurosaki2, Kentaroh Miyoshi3, Masaomi Yamane3, Shinichiro Miyoshi3, Takahiro Oto2.   

Abstract

Single living-donor lobar lung transplantation provides acceptable results for critically ill children; however, an additional lung transplantation may be required in the future as the recipient grows. We describe a case of successful lung retransplantation in a grown-up patient after single lobar lung transplantation in childhood. A 23-year-old man underwent bilateral cadaveric lung retransplantation for chronic lung allograft dysfunction 13 years after right single living-donor lobar transplantation for idiopathic pulmonary arterial hypertension performed at the age of 10 years. The postoperative course was uneventful. The patient had received growth hormone therapy at a local hospital for 3 years until the development of chronic lung allograft dysfunction after the initial transplantation. Pediatric recipients undergoing single living-donor lobar lung transplantation should be cautiously followed for potential retransplantation.

Entities:  

Keywords:  Bronchiolitis obliterans; Lung transplantation; Pediatric; Pulmonary hypertension; Reoperation

Mesh:

Year:  2017        PMID: 28101803     DOI: 10.1007/s11748-016-0732-2

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  8 in total

1.  The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation.

Authors:  Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Fabienne Dobbels; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2014-08-14       Impact factor: 10.247

2.  The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric lung and heart-lung transplantation report--2014; focus theme: retransplantation.

Authors:  Christian Benden; Samuel B Goldfarb; Leah B Edwards; Anna Y Kucheryavaya; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Roger D Yusen; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2014-08-17       Impact factor: 10.247

3.  Living related donor middle lobe lung transplant in a pediatric patient.

Authors:  Takahiro Oto; Kentaroh Miyoshi; Seiichiro Sugimoto; Masaomi Yamane
Journal:  J Thorac Cardiovasc Surg       Date:  2014-11-01       Impact factor: 5.209

4.  Lung retransplantation in children: appropriate when selectively applied.

Authors:  Brandi B Scully; Farhan Zafar; Marc G Schecter; Joseph W Rossano; George B Mallory; Jeffrey S Heinle; David L S Morales
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

5.  Long-term outcomes of bilateral lobar lung transplantation.

Authors:  Ilhan Inci; Mace M Schuurmans; Peter Kestenholz; Didier Schneiter; Sven Hillinger; Isabelle Opitz; Annette Boehler; Walter Weder
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-22       Impact factor: 4.191

Review 6.  Growth following solid organ transplantation in childhood.

Authors:  M L Laster; R N Fine
Journal:  Pediatr Transplant       Date:  2014-01-20

7.  A decade of living lobar lung transplantation: recipient outcomes.

Authors:  Vaughn A Starnes; Michael E Bowdish; Marlyn S Woo; Richard G Barbers; Felicia A Schenkel; Monica V Horn; Renzo Pessotto; Eric M Sievers; Craig J Baker; Robbin G Cohen; Ross M Bremner; Winfield J Wells; Mark L Barr
Journal:  J Thorac Cardiovasc Surg       Date:  2004-01       Impact factor: 5.209

8.  Long-term follow-up of living-donor single lobe transplantation for idiopathic pulmonary arterial hypertension in a child.

Authors:  Shinichi Toyooka; Yoshifumi Sano; Masaomi Yamane; Takahiro Oto; Megumi Okazaki; Kengo Fukushima Kusano; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02       Impact factor: 5.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.